Establishment Labs Holdings (ESTA) EBIT Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 61.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.58% |
| Dec 31, 2025 | 78.95% |
| Sep 30, 2025 | 69.37% |
| Jun 30, 2025 | -50.97% |
| Mar 31, 2025 | -91.83% |
| Dec 31, 2024 | 15.58% |
| Sep 30, 2024 | 37.55% |
| Jun 30, 2024 | 31.86% |
| Mar 31, 2024 | -8.26% |
| Dec 31, 2023 | -68.05% |
| Sep 30, 2023 | -100.04% |
| Jun 30, 2023 | -31.78% |
| Mar 31, 2023 | -46.37% |
| Dec 31, 2022 | -40.51% |
| Sep 30, 2022 | -16.29% |
| Jun 30, 2022 | -124.56% |
| Mar 31, 2022 | -165.98% |
| Dec 31, 2021 | -16.83% |
| Sep 30, 2021 | -249.05% |
| Jun 30, 2021 | 51.74% |
| Mar 31, 2021 | 72.80% |
| Dec 31, 2020 | -82.00% |
| Sep 30, 2020 | 70.44% |
| Jun 30, 2020 | -2.34% |
| Mar 31, 2020 | 8.14% |
| Dec 31, 2019 | 48.90% |
| Sep 30, 2019 | -44.97% |
| Jun 30, 2019 | -48.54% |
| Mar 31, 2019 | -191.25% |
| Dec 31, 2018 | -87.90% |
| Sep 30, 2018 | -1.26% |
| Jun 30, 2018 | -15.23% |